Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 76, Issue 3, Pages 393-403Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2016.07.065
Keywords
cardiovascular disease; chronic kidney disease; comorbidities; Crohn's disease; depression; infection; lymphoma; metabolic syndrome; nonalcoholic fatty liver disease; psoriasis; psoriatic arthritis; screening; vaccination
Categories
Funding
- National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24AR064310, T32AR00746532, K23AR063764, K23AR068433]
- Dermatology Foundation Career Development Award
- Intramural Research Program at the National Institutes of Health [ZIAHL006193-02]
- National Institute for Health Research Clinician Scientist Fellowship [NIHR/CS/010/014]
- Pfizer Inc
- AbbVie
- Celgene
- Amgen
- Eli Lilly
- Janssen
- Novartis Corp
- Regeneron
- National Institute for Health Research [NIHR/CS/010/014] Funding Source: researchfish
Ask authors/readers for more resources
As summarized in the first article in this continuing medical education series, the currently available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic disease. Emerging data also suggest associations between psoriasis and other comorbidities beyond psoriatic arthritis, including chronic kidney disease, inflammatory bowel disease, hepatic disease, certain malignancies, infections, and mood disorders. Recognizing the comorbid disease burden of psoriasis is essential for ensuring comprehensive care of patients with psoriasis. The clinical implications of the comorbid diseases that are associated with psoriasis and recommendations for clinical management are reviewed in this article.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available